regions at the 3' and 5' ends of the influenza B virus vRNA segment four are required for genome 34 packaging, with the first 30 nucleotides at each end essential for this process. Synonymous 35 mutation of these regions led to virus attenuation, an increase in defective particle production and 36 a reduction in packaging of multiple vRNAs. Overall our data suggest that the influenza B virus 37 vRNA gene segments likely interact with each other during the packaging process, which is driven 38 by cis-acting packaging signals that extend into protein coding regions of the vRNA.
Introduction 58
Influenza A and B viruses are members of the Orthomyxoviridae family, containing an eight-59 segmented negative sense RNA genome. Each segment encodes one or more proteins that show 60 high levels of similarity in structure and function between the two types of viruses, despite 61 significant differences in amino acid identity (Palese & Shaw, 2007) . Influenza A and B virions also 62
show high levels of structural similarity, however a significant difference has been observed in 63 genome arrangement within the core. The genome of both viruses is in the form of eight viral 64 ribonucleoprotein complexes (vRNP) consisting of the viral RNA (vRNA) encapsidated by 65 nucleoprotein and associated with a heterotrimeric polymerase complex. Electron microscopic 66 analysis of influenza A virus particles demonstrated that the vRNPs are arranged in a highly 67 ordered "7+1" orientation in which all segments align in a circular fashion with one segment in the 68 centre (Noda et al., 2006) . However recent evidence suggests that this does not occur in influenza 69 B viruses, as the vRNPs appear to twist around each other (Katz et al., 2014) . This suggests that 70 influenza A and B viruses potentially adopt different mechanisms for genome packaging. 71
72
It is now widely accepted that influenza A viruses utilise a selective packaging process by which a 73 single copy of each of the vRNPs is packaged into progeny virions in a process likely driven by 74 bipartite cis-acting sequences within the vRNAs (Gerber et al., 2014) . Although early work 75 suggested that the non-coding regions at the extreme termini of each vRNA were the minimal 76 determinants of genome packaging (Luytjes et al., 1989) , more recent studies have shown that the 77 extreme 5' and 3' ends of the protein coding regions are required for optimal genome packaging 78 (reviewed in Hutchinson et al., 2010) . These cis-acting sequences are hypothesized to be 79 responsible not only for packaging each genome segment into the virion but also for forming 80 interactions between segments (Fournier et al., 2012) to create a complex of vRNPs, thereby 81 acting as bundling signals to allow a single copy of each vRNP to be packaged (Goto et al., 2013) . 82
It is tempting to speculate that this may be responsible for the "7+1" genome arrangement, which 83 questions whether influenza B viruses contain similar cis-acting packaging sequences due to the 84 the first 30 nucleotides of the BHA coding region at the 3' end of the negative sense vRNA (3m30 143 mutations) or between nucleotides 31-60 (3m60 mutations) (Fig. 2a) . Similar mutations were 144 introduced into the BHA coding region at the 5' end of the negative sense vRNA. Viruses were 145 generated containing mutations at either one or both termini. The rBHA-3m30/5m30 virus took 146 significantly longer to recover due to a propensity to generate defective particles, therefore this 147 virus was plaque purified to remove these particles prior to experimentation. The only virus 148 containing mutations at a single end of the gene that demonstrated attenuated replication kinetics 149 compared to the rBHA wt (wild type) virus was the rBHA-3m30 virus (Fig. 2b) . Further attenuation 150 was observed when combining the 3m30 mutation with mutations in the BHA coding region at the 151 5' end of the vRNA, with the rBHA-3m30/5m30 virus demonstrating the largest degree of 152 attenuation (Fig. 2c ). This confirmed that the terminal 30 nucleotides at both ends of the BHA 153 coding region have a significant effect on virus replication. This is remarkably similar to the results 154 of a previous study in which the packaging signals of the influenza A virus segment eight were 155 characterised (Fujii et al., 2005) . In this study synonymous mutations introduced into the 5' end of 156 the coding region did not alter viral replication, whereas mutations in the 3' end of the coding 157 region resulted in a slight attenuation, which was enhanced by introducing the mutations into both 158 the 3' and 5' coding regions. The phenotype of the double mutant reported by Fujii et al. was 159 therefore remarkably similar to the rBHA-3m30/5m30 virus, suggesting these sequences are 160 essential for efficient viral replication of both influenza A and B viruses, possibly indicating similar 161 functional requirements. 162
163
As the 3m30/5m30 mutations may have reduced the efficiency of genome packaging, resulting in 164 higher levels of defective virus production, the particle to infectivity ratio of all viruses stocks was 165
analysed. The only virus that demonstrated a marked increase in the number of defective particles 166 was the rBHA-3m30/5m30 virus (Fig. 2d) . The 36 and 48 hour time point samples ( Fig. 2a and b ) 167 of viruses containing the 3m30 mutations were analysed for particle to infectivity ratios. The only 168 virus that demonstrated a significant increase in defective particles at both time points was the 169 rBHA-3m30/5m30 virus (Fig 2e) . The level of defective virus particles increased for all viruses 170 between the two time points, however while most viruses demonstrated a 2-to 7-fold increase,there was a 39-fold increase in rBHA-3m30/5m30 defective particles. The propensity for this virus 172 to generate defective particles was likely responsible for its attenuation in the replication analysis. 173 174 Sequence analysis of vRNA segment four of multiple influenza B viruses isolated between 1940 175 and 2014 shows that the 3m30, 3m60, 5m30 and 5m60 regions of the genome are highly 176 conserved, with the 3m30 region completely conserved in all analysed sequences (Fig. 3a) . The 177 lack of synonymous mutations in the 3m30 region over a 74-year time period may suggest that the 178 sequence integrity of the RNA in this region is essential for virus viability, potentially through 179 contributing to efficient genome packaging. This is not surprising given that previous studies have 180
shown that the areas of various influenza A virus vRNA segments that contain the highest levels of 181 sequence conservation are found in the terminal ends of the coding regions that have been 182 implicated as packaging signals (Gog et al., 2007; Marsh et al., 2007) . As the mutated regions of 183 the rBHA-3m30/5m30 virus potentially represent packaging signals, changes in RNA sequence or 184 secondary structure may have reduced the efficiency of segment four packaging. However it was 185 also possible that such changes had affected the efficiency of mRNA transcription from the mutant 186 vRNA, thereby leading to viral attenuation. To address this vRNA segment four from the wt and 187 rBHA-3m30/5m30 viruses was cloned into a plasmid under the control of the human RNA 188 polymerase I promoter allowing its expression in a mini-genome assay. The results showed similar 189 levels of BHA for both wt and mutant segments ( Fig. 3b and c) . This demonstrated that the 190 3m30/5m30 mutations did not affect the ability of the polymerase to transcribe BHA mRNA and 191 therefore did not affect BHA protein levels. 192 193 To analyse whether the BHA-3m30/5m30 mutations reduced vRNA content in released virions, 194 resulting in increased levels of defective particles shown in Fig. 2(d (Fig. 3d) . A slight reduction in overall viral protein levels were observed in the mutant virions 199 compared to those of rBHA wt, suggesting the presence of fewer particles, however a greater8 reduction was observed in BNP levels compared to other proteins. To accurately identify the viral 201 proteins and to quantify their levels in both viruses the viral proteins were analysed by 202 immunoblotting. While BM1 and BHA levels were similar for both viruses the BNP level in the 203 mutant was only 63% that of wt (Fig. 3e) . As BNP is associated with the viral genome this 204 reduction likely indicated reduced vRNA content in the virions. This was confirmed by qRT-PCR 205 analysis (Fig. 3f) . Levels of three vRNA segments were present in the mutant virions at only 56 to 206 74% those of wt virus, which is a similar reduction to the levels of BNP observed in Fig. 3 with the defective segment retaining both the non-coding regions and a portion of the coding 227 regions at either terminus (Duhaut & Dimmock, 1998; Duhaut & McCauley, 1996; Nayak et al.,Dimmock, 2000) . It is plausible that short coding regions were retained as they contained the cis- and that these signals extend into the coding regions. Our results show that the extreme terminal 235 3' and 5' ends of the coding regions of the influenza B virus vRNA segment four are required for 236 efficient genome packaging, with the first 30 nucleotides at the 3' end having the greatest influence 237 on packaging efficiency, similar to findings in the context of influenza A virus segments six and 238 eight packaging (Fujii et al., 2005; Fujii et al., 2003) . It was previously shown through truncation 239 analysis that the terminal 3' and 5' ends of the coding region of the influenza A virus segment four 240 are required for efficient packaging to occur (Marsh et al., 2007; Watanabe et al., 2003) . However 241 unlike the findings for influenza B virus segment four, systematic synonymous mutagenesis in the 242 influenza A virus segment revealed that a 15 nucleotide stretch in the terminal 80 nucleotides at 243 the 5' end of the coding region had the greatest influence on packaging efficiency (Marsh et al., 244 2007) . Unfortunately the studies of Marsh et al. did not include analysis of viruses containing 245 synonymous mutations at both the 3' and 5' ends of the same segment, therefore it is unknown 246 whether this would have enhanced the attenuation of a recombinant virus, similar to the rBHA-247 3m30/5m30 virus in the current study. It is likely that these differences in segment four packaging 248 sequence requirements between the two viruses are influenced by the mechanism of vRNA 249 interaction between the individual segments, especially as it has been reported that vRNPs interact 250 during transport to the site of assembly (Chou et al., 2013; Gavazzi et al., 2013; Lakdawala et al., 251 2014) . Although our results suggest that the mechanism of genome packaging utilised by influenza 252 A and B viruses is similar, the fact that the 3' end of the coding region was more important in 253 packaging of influenza B virus vRNA segment four compared to the 5' end in influenza A viruses 254 may suggest that there is a difference in the mechanism behind vRNA-vRNA interaction formation 255 between the two viruses, or that the influenza B virus vRNA segment four interacts with different 256 vRNPs compared to its influenza A virus counterpart. Further experiments using labelled vRNPs 257 (Lakdawala et al., 2014) for efficient growth in eggs by reverse genetics could offer significant advantages for vaccine 275 production purposes (Hoffmann et al., 2002) . However natural mutations in the coding regions of 276 these segments may reduce the efficiency of vRNA packaging, which has previously been shown 277 to be a limiting factor in influenza A virus reassortment (Essere et al., 2013) . Therefore ensuring 278 these signals are optimal for efficient recombinant virus generation could enhance vaccine seed 279 production. 280 281
Materials and methods 282

Cells and Viruses 283
293T and MDCK cells were maintained in Dulbecco's modified Eagle's medium (DMEM) 284 (Invitrogen) supplemented with 10% foetal calf serum (FCS) at 37 °C with 5% CO 2 . 285 B/Yamanashi/98 wild-type (rBHA wt) and mutant viruses were generated using plasmid-based 286 reverse genetics as previously described (Hoffmann et al., 2002) . Briefly, 293T cells weretransfected with eight genome-encoding bi-directional (pAB) plasmids using BHA coding regions at either or both termini were amplified using specific primer sets, these PCR 307 products were fused to the 3' or 5' non-coding region by overlapping PCR followed by insertion of 308 the eGFP coding sequence by overlapping PCR. The resultant products were inserted into pHH-21 309 as above. All primer sequences are available upon request. For creation of mutant viruses 310 synonymous mutations were introduced into the BHA open reading frame within the pAB-HA 311 reverse genetics plasmid by site-directed mutagenesis and the resultant plasmids substituted into 312 the reverse genetics system. The presence of the desired mutations were confirmed by DNA 313 sequencing. To generate the pHH-BHA wt and pHH-BHA-3m30/5m30 plasmids total vRNA was 314 extracted from rBHA wt or rBHA-3m30/5m30 virus and vRNA segment four was amplified by 315 reverse transcriptase PCR. The resultant cDNA was inserted into the pHH-21 plasmid in anegative sense orientation between the human RNA polymerase I promoter and terminator 317 sequences using BsmBI restriction sites. Segment four sequences were confirmed by DNA 318 sequencing. 319 320
Mini-genome assay 321
To test expression of GFP from the mini-genome plasmids, 293T cells in 12-well plates were 322 transfected with 500 ng of pAB expression plasmids encoding PB1, PB2, PA and NP of 323 6 virus particles are required to achieve an HA titre of 1 (Donald & 360 Isaacs, 1954) , the HA titres of the virus stocks were multiplied by 1x10 6 to determine the number of 361 virus particles per ml in each sample. The infectious titre of each sample (pfu/ml) was determined 362 by plaque assay titration on MDCK cells. The particle to infectivity ratio (particles/ml : plaque 363 forming units/ml) was determined for each sample. 364 365
Viral protein analysis by SDS-PAGE 366
To analyse BHA mRNA transcription and protein expression levels from rBHA wt or rBHA-367 3m30/5m30 vRNA segment four, 1 µg of the pHH-BHA or pHH-BHA3m30/5m30 plasmids 368 (described above) were transfected into 293T cells in a 12 well plate alongside 500 ng of pAB 369 expression plasmids encoding PB1, PB2, PA and NP of B/Yamanashi/98 virus. 24 hours post-370 transfection cells were lysed in 2x disruption buffer (6 M urea, 2 M β-mercaptoethanol, 4% sodium 371 dodecyl sulphate), proteins separated by SDS-PAGE and transferred to Immobilon-FL 372 0.1% Tween 20, 5% dried milk) and incubated with an anti-B/Hong Kong/73 polyclonal antisera (to 374 detect viral BHA and BNP proteins) or an anti-actin monoclonal antibody. Protein detection was 375 performed using IRDye 680-or IRDye 800-conjugated secondary antibodies (Licor) on an Odyssey 376 CLx near infrared scanner (Licor), images were collected and protein band intensities were 377 quantified using ImageStudio (Licor). 378
379
To analyse virion protein content 500 000 HA units of rBHA wt and rBHA-3m30/5m30 viruses were 380 purified by sucrose gradient ultracentrifugation. Virus samples were placed onto a 30% sucrose 381 cushion and subjected to ultracentrifugation at 112 000 x g for 2.5 h at 4 °C. Pelleted viruses were 382 resuspended in 500 µl NTE buffer (150mM NaCl, 10mM Tris-HCl pH 7.5, 1mM EDTA) and placed 383 onto a continuous 30-60% sucrose gradient, followed by ultracentrifugation at 112 000 x g for 2.5 h 384 at 4 °C. Virus bands were extracted from the gradient and pelleted by ultracentrifugation at 112 385 000 x g for 2 h at 4 °C. Purified virus pellets were resuspended in 50 µl NTE buffer. All virus 386 purifications were performed in triplicate. Viral proteins in 5 µl of each virus sample were then 387 separated by SDS-PAGE and analysed by coomassie staining or immunoblotting using the anti-388 B/Hong Kong/73 polyclonal antisera as described above. Protein bands were detected and 389 quantified for BHA, BNP and BM1. 390 391
Analysis of virion vRNA content by quantitative reverse transcriptase-PCR 392
Total vRNA was extracted from three separate samples of rBHA wt or rBHA-3m30/5m30 virus 393 (5.12 x10 9 particles for each virus as determined by haemagglutination assay). vRNA segments 394 four, five and eight were reverse transcribed using gene-specific primers and RevertAid Premium 395
Reverse Transcriptase (Thermo Scientific). For qPCR viral gene-specific primers (sequences 396 available on request) were designed to amplify a 150 nt fragment of DNA and various 397 concentrations of primers were optimised against each other by qPCR using various 398 concentrations of pAB-HA, pAB-NP or pAB-NS as standardized templates. cDNAs generated by 399 reverse transcription were then assayed by qPCR using serial four-fold dilutions of cDNA and 400 appropriate concentrations of gene-specific primers using Precision Mastermix (Primer Design) on 401 a Stratagene Mx3005P real-time PCR thermocycler. A standard curve was generated using serial10-fold dilutions of pAB-HA, pAB-NP or pAB-NS and used to convert ct values into cDNA 403 concentrations. 404 405 Gog, J. R., Afonso Edos, S., Dalton, R. M., Leclercq, I., Tiley, L., Elton, D., 
